ClinicalTrials.govpublic full text
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
colon cancer, irinotecan, folfiri, genotyping, ugt1a1, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847668
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.